SCHUMER, GILLIBRAND ANNOUNCE OVER $450,000 IN RECOVERY ACT FUNDING COMING TO UPSTATE MEDICAL UNIVERSITY FOR HEALTH RESEARCH

Normal 0 false false false ENUS XNONE XNONE MicrosoftInternetExplorer4

U.S. Senators Charles E. Schumer and Kirsten Gillibrand today announced that the American Recovery and Reinvestment Act (ARRA) will provide a total of $462,114 in funding through the National Institutes of Health (NIH) for biomedical research projects at Upstate Medical University. The ARRA will provide a total of $64,826,308 for projects statewide, including $13,288,446 for those at upstate institutions.

 

"This funding for biomedical research is a wise investment in the Central New York economy," said Schumer. "Not only will these federal dollars help New York institutions tackle our biggest health issues, but we will be creating research and teaching positions in the region. I will continue to fight for funding to keep our state's worldclass schools and research facilities at the forefront of medicine."

 

"It is critical that we invest in the lifesaving research at our world class medical facilities in Central New York," said Senator Gillibrand. "Federal funding for this cutting edge research will advance research and treatment while promoting economic growth for New York. I will continue to work with Senator Schumer to make sure New York gets its fair share of federal dollars."

 

The funding for Upstate Medical University will be broken down as follows:

• $353,250 for the study of deficiency of SHP1 expression and function in multiple sclerosis patients
• $108,864 for the study of the genetics of schizophrenia in Oceanic Palau

 

NIH funds biomedical research and research training at more than 3,000 institutions in the fifty states and territories.